GLP-1 users may be making a major weight-loss mistake, new study suggests
Among those taking GLP-1 medications for weight loss, exercise rates are decreasing, according to new research. The study, set to be presented at ENDO 2026 (the Endocrine Society’s annual meeting) in Chicago this week, found that adults with obesity who lost weight with a GLP-1, such as Ozempic or Wegovy, “significantly reduced” their physical activity. In an Endocrine … Read more